Testing effectiveness (Phase 2)Study completedNCT05348811What this trial is testingHAIC Combined With Donafenib and Sintilimab for Unresectable ICCWho this might be right forCholangiocarcinoma Zhongda Hospital 25
Not applicableStudy completedNCT07224737What this trial is testingLiquid Biopsy Using Exosomal miRNA Enables Risk Stratification of Potential Metastasis in Patients With Intrahepatic Cholangiocarcinoma.Who this might be right forIntrahepatic Cholangiocarcinoma (Icc) City of Hope Medical Center 230
Testing effectiveness (Phase 2)Looking for participantsNCT06852287What this trial is testingPhase II Clinical Study of GemOX Hepatic Arterial Infusion Combined with Lenvatinib and Toripalimab for Advanced and Unresectable Intrahepatic Cholangiocarcinoma and Gallbladder CancerWho this might be right forIntrahepatic Cholangiocarcinoma (Icc)Gall Bladder Cancer Tianjin Medical University Cancer Institute and Hospital 33
Testing effectiveness (Phase 2)UnknownNCT03633773What this trial is testingSafety and Efficacy Evaluation of MUC-1 CART in the Treatment of Intrahepatic CholangiocarcinomaWho this might be right forIntrahepatic Cholangiocarcinoma Second Affiliated Hospital, School of Medicine, Zhejiang University 9
Not applicableUnknownNCT02184871What this trial is testingNext Generation Sequencing in Intrahepatic CholangiocarcinomaWho this might be right forIntrahepatic Cholangiocarcinoma University of Bologna 45
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06375642What this trial is testingA Single Arm, Single Centered Phase II Trial on the Combination of Adebrelimab, Surufatinib and Irinotecan Liposome-based HAIC in Advanced iCCWho this might be right forIntrahepatic Cholangiocarcinoma Tianjin Medical University Cancer Institute and Hospital 30
Large-scale testing (Phase 3)Looking for participantsNCT05342194What this trial is testingToripalimab Plus Lenvatinib and Gemcitabine-based Chemotherapy in 1L Treatment of Advanced ICC: a Phase III StudyWho this might be right forIntrahepatic Cholangiocarcinoma Shanghai Junshi Bioscience Co., Ltd. 480
Testing effectiveness (Phase 2)Looking for participantsNCT06721286What this trial is testingToripalimab Combined With Gemcitabine and Cisplatin (GemCis) as Preoperative Neoadjuvant Therapy for Resectable Intrahepatic CholangiocarcinomaWho this might be right forIntrahepatic Cholangiocarcinoma (Icc) Tianjin Medical University Cancer Institute and Hospital 70
Testing effectiveness (Phase 2)Active Not RecruitingNCT06777316What this trial is testingAn FGFR2/3 Inhibitor (CGT4859) in Patients With Cholangiocarcinoma and Other Advanced Solid TumorsWho this might be right forIntrahepatic Cholangiocarcinoma (Icc)CholangiocarcinomaOther Solid Tumors, Adult+9 more Cogent Biosciences, Inc. 110
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07353827What this trial is testingFOLFOX-HAIC Combined With Donafenib and Pucotenlimab as First-Line Treatment for Unresectable Intrahepatic CholangiocarcinomaWho this might be right forIntrahepatic Cholangiocarcinoma (Icc)Hepatic Arterial Infusion Chemotherapy Sun Yat-sen University 36
Not applicableNot Yet RecruitingNCT07208526What this trial is testingTrial of Surgical Decision-Making Guided by TDTP-RECISTWho this might be right forIntrahepatic Cholangiocarcinoma (Icc)Conversion TherapyTDTP-RECIST+1 more Shanghai Zhongshan Hospital 270
Testing effectiveness (Phase 2)Looking for participantsNCT07070700What this trial is testingCryoablation Combined With Lenvatinib Plus QL1706 (Iparomlimab/Tuvonralimab) in Patients With Advanced Intrahepatic CholangiocarcinomaWho this might be right forIntrahepatic Cholangiocarcinoma (Icc) Fudan University 56
Testing effectiveness (Phase 2)Looking for participantsNCT05678270What this trial is testingICP-192 in Patients With FGFR2-Rearranged Unresectable or Metastatic Intrahepatic CholangiocarcinomaWho this might be right forIntrahepatic Cholangiocarcinoma (ICC) Beijing InnoCare Pharma Tech Co., Ltd. 70
Not applicableLooking for participantsNCT06505486What this trial is testingGEMOX-HAIC Plus GEM-SYS in Combination With Lenvatinib and PD-1 Inhibitor for Large Unresectable ICCWho this might be right forIntrahepatic Cholangiocarcinoma Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 21
Large-scale testing (Phase 3)Looking for participantsNCT04353375What this trial is testingHMPL-453 Tartrate in Advanced Intrahepatic CholangiocarcinomaWho this might be right forAdvanced Intrahepatic CholangiocarcinomaSolid Tumor, Adult Hutchmed 235
Testing effectiveness (Phase 2)Looking for participantsNCT06859684What this trial is testingHepatic Arterial Infusion Chemotherapy (HAIC) Combined With Durvalumab and Lenvatinib in Patients With Locally Advanced or Metastatic Intrahepatic Cholangiocarcinoma: a Phase 2 Study(HAIC-quad Trial)Who this might be right forIntrahepatic Cholangiocarcinoma (Icc)HAICDurvalumab West China Hospital 25
Not applicableLooking for participantsNCT07476651What this trial is testingScout Dose of Resin MicrospheresWho this might be right forRadioembolizationHepatocellular Carcinoma (HCC)Intrahepatic Cholangiocarcinoma (ICC)+1 more Seoul National University Hospital 30
Testing effectiveness (Phase 2)Study completedNCT05236699What this trial is testingA Clinical Study of DEB-TACE Combined With Surufatinib and Camrelizumab in the Treatment of Inoperable or Metastatic ICCWho this might be right forIntrahepatic Cholangiocarcinoma Tongji Hospital 23
Large-scale testing (Phase 3)UnknownNCT03771846What this trial is testingHAIC Versus Systemic Chemotherapy for Unresectable ICCWho this might be right forIntrahepatic Cholangiocarcinoma Shi Ming 188
Testing effectiveness (Phase 2)Ended earlyNCT02994251What this trial is testingA Trial of Systemic Chemotherapy in Combination With Conventional Transarterial Chemoembolization in Patients With Advanced Intra-Hepatic CholangiocarcinomaWho this might be right forUnresectable Intrahepatic Cholangiocarcinoma Yale University 1